TELO
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ: TELO · HEALTHCARE · BIOTECHNOLOGY
$1.40
-3.45% today
Updated 2026-04-30
Market cap
$99.72M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Telomir Pharmaceuticals, Inc. Common Stock (TELO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-317.60%
ROA
-152.00%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-138131.00 | — | — | — |
| 2022 | $0.00 | $-854147.00 | — | — | — |
| 2023 | $0.00 | $-13.07M | — | — | — |
| 2024 | $0.00 | $-16.53M | — | — | — |
| 2025 | $0.00 | $-10.41M | — | — | — |